Table 4 Association between sociodemographic, clinical, treatment, and transplant characteristics on self-reported pulmonary outcomes.

From: Transplant characteristics and self-reported pulmonary outcomes in Swiss childhood cancer survivors after hematopoietic stem cell transplantation—a cohort study

 

OR

95% CI

p value

Age at diagnosis

1.13

0.99–1.28

0.055

Age at questionnaire

1.00

0.91–1.08

0.892

Bleomycin exposure

1.57

0.28–8.81

0.608

Median CED dose >11,300 mg/m2

1.74

0.57–5.33

0.330

Thoracic surgery

3.91

0.95–16.02

0.058

Thoracic radiotherapy

1.58

0.49–5.14

0.446

  1. Results from multivariable logistic regression analysis, adjusted for all factors in the table. N = 132, median 18.4 years at study.
  2. CED cyclophosphamide equivalent dose, CI confidence interval, OR Odds ratio.
Back to article page